medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2021-35-52-56medalphabet-2361Research ArticleСТОМАТОЛОГИЯDENTISTRYМанифестный гипертиреоз у пациентки с аутоиммунным гепатитом (клиническое наблюдение)Manifest hyperthyroidism in patient with autoimmune hepatitis (clinical observation)https://orcid.org/0000-0002-6581-7017ЛивзанМ. А.LivzanM. A.

Ливзан Мария Анатольевна - доктор медицинских наук, профессор, ректор, зав. кафедрой факультетской терапии и гастроэнтерологии, Scopus ID: 24341682600

Livzan Maria A. - DM Sci (habil.), professor, rector, head of Dept of Faculty Therapy and Gastroenterology. Scopus ID: 24341682600

mlivzan@yandex.ruhttps://orcid.org/0000-0001-9370-4768ГаусО. В.GausO. V.

Гаус Ольга Владимировна - кандидат медицинских наук, доцент кафедры факультетской терапии и гастроэнтерологии, Scopus ID: 56598554900

Gaus Olga V. - PhD Med, associate professor at Dept of Faculty Therapy and Gastroenterology. Scopus ID: 56598554900

gaus_olga@bk.ruhttps://orcid.org/0000-0001-5245-7190ГавриленкоД. А.GavrilenkoD. A.

Гавриленко Дарья Александровна - студентка IV курса лечебного факультета

Gavrilenko Darya A. - 4th year student of the Faculty of Medicine

ФГБОУ ВО Омский государственный медицинский университет Минздрава РоссииРоссияOmsk State Medical UniversityRussian Federation202118122021035Практическая гастроэнтерология (3)5256Copyright © Ливзан М.А., Гаус О.В., Гавриленко Д.А., 20212021Ливзан М.А., Гаус О.В., Гавриленко Д.А.Livzan M.A., Gaus O.V., Gavrilenko D.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/2361

Среди пациентов с аутоиммунным гепатитом сопутствующие аутоиммунные заболевания встречаются в 40 % случаев. Наиболее часто в клинической практике с аутоиммунным гепатитом ассоциируются первичный билиарный холангит, первичный склерозирующий холангит и патология щитовидной железы. При этом, если в отношении сочетанного течения аутоиммунных заболеваний печени друг с другом накоплен некоторый опыт ведения, что нашло свое отражение в соответствующих клинических рекомендациях, то данные об особенностях коморбидности при аутоиммунном гепатите и аутоиммунных заболеваниях щитовидной железы весьма ограниченны. В данной статье представлено собственное клиническое наблюдение пациентки с манифестацией тиреотоксикоза на фоне аутоиммунного гепатита.

Among patients with autoimmune hepatitis concomitant autoimmune diseases occur in 40 % of cases. The most commonly associated autoimmune hepatitis is primary biliary cholangitis, primary sclerosing cholangitis and thyroid disease. With regard to the association of autoimmune liver diseases with each other there is experience in management and this is reflected in the clinical guidelines. Information on the features of comorbidity in autoimmune hepatitis and autoimmune thyroid diseases is very limited. This article presents our own clinical observation of the manifestation of thyrotoxicosis against the background of autoimmune hepatitis.

аутоиммунный гепатитдиффузный токсический зобтиреотоксикозклиническое наблюдениетиреостатикиглюкокортикостероидыautoimmune hepatitisdiffuse toxic goiterthyrotoxicosisclinical observationthyreostaticsglucocorticosteroidsReferencesEuropean Association for the Study of the Liver. EASL Clinical Practice Guide-lines: Autoimmune hepatitis. J Hepatol. 2015; 63 (4): 971–1004. https://doi.org/10.1016/j.jhep.2015.06.030European Association for the Study of the Liver. EASL Clinical Practice Guide-lines: Autoimmune hepatitis. J Hepatol. 2015; 63 (4): 971–1004. https://doi.org/10.1016/j.jhep.2015.06.030Zachou K., Muratori P., Koukoulis G. K., Granito A., Gatselis N., Fabbri A. et al. Review article: autoimmune hepatitis – current management and challeng-es. Aliment Pharmacol. Ther. 2013; 38 (8): 887–913. https://doi.org/10.1111/apt.12470Zachou K., Muratori P., Koukoulis G. K., Granito A., Gatselis N., Fabbri A. et al. Review article: autoimmune hepatitis – current management and challenges. Aliment Pharmacol. Ther. 2013; 38 (8): 887–913. https://doi.org/10.1111/apt.12470Stravitz R. T., Lefkowitch J. H., Fontana R. J., Gershwin M. E., Leung P. S., Sterling R. K., et al. Autoimmune acute liver failure: proposed clinical and his-tological criteria. Hepatology. 2011; 53 (2): 517–26. https://doi.org/10.1002/hep.24080Stravitz R. T., Lefkowitch J. H., Fontana R. J., Gershwin M. E., Leung P. S., Sterling R. K., et al. Autoimmune acute liver failure: proposed clinical and his-tological criteria. Hepatology. 2011; 53 (2): 517–26. https://doi.org/10.1002/hep.24080Кононов А. В., Ливзан М. А. Медицина, основанная на доказательствах в практике клинического патолога. Сибирский консилиум. 2002; (2): 8–22.Kononov A. V., Livzan M. A. Evidence-based medicine in the practice of a clinical pathologist. Sibirskii Konsilium – Siberian Council. 2012; (2): 8–22.Teufel A., Weinmann A., Kahaly G. J., Centner C., Piendl A., Wörns M. et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol. 2010; 44 (3): 208–13. https://doi.org/10.1097/MCG.0b013e3181c74e0d. PMID: 20087196Teufel A., Weinmann A., Kahaly G. J., Centner C., Piendl A., Wörns M. et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol. 2010; 44 (3): 208–13. https://doi.org/10.1097/MCG.0b013e3181c74e0d. PMID: 20087196Muratori P., Fabbri A., Lalanne C., Lenzi M., Muratori L. Autoimmune liv-er disease and concomitant extrahepatic autoimmune disease. Eur. J. Gastroenterol. Hepatol. 2015; 27 (10): 1175–9. https://doi.org/10.1097/MEG.0000000000000424Muratori P., Fabbri A., Lalanne C., Lenzi M., Muratori L. Autoimmune liv-er disease and concomitant extrahepatic autoimmune disease. Eur. J. Gastroenterol. Hepatol. 2015; 27 (10): 1175–9. https://doi.org/10.1097/MEG.0000000000000424Malik R., Hodgson H. The relationship between the thyroid gland and the liver. QJM. 2002; 95 (9): 559–69. https://doi.org/10.1093/qjmed/95.9.559Malik R., Hodgson H. The relationship between the thyroid gland and the liver. QJM. 2002; 95 (9): 559–69. https://doi.org/10.1093/qjmed/95.9.559Корнеева О. Н., Драпкина О. М., Павлов Ч. С., Бакулин И. Г. и др. Неалко-гольный стеатогепатит при метаболическом синдроме. Приложение к журналу Consillium Medium. 2007; (2): 18–21.Korneeva O. N., Drapkina O. M., Pavlov Ch.S., Bakulin I. G. Ivashkin V. T. Non-alcoholic steatohepatitis in metabolic syndrome. Consillium Medium Magazine Supplement. 2007; (2): 18–21.Upadhyay G., Singh R., Kumar A., Kumar S., Kapoor A., Godbole M. M. Severe hyperthyroidism induces mitochondria-mediated apoptosis in rat liver. Hepatology. 2004; 39 (4): 1120–30. https://doi.org/10.1002/hep.20085Upadhyay G., Singh R., Kumar A., Kumar S., Kapoor A., Godbole M. M. Severe hyperthyroidism induces mitochondria-mediated apoptosis in rat liver. Hepatology. 2004; 39 (4): 1120–30. https://doi.org/10.1002/hep.20085Khemichian S., Fong T. L. Hepatic dysfunction in hyperthyroidism. Gastroen-terol Hepatol (N.Y.). 2011; 7 (5): 337–9.Khemichian S., Fong T. L. Hepatic dysfunction in hyperthyroidism. Gastroen-terol Hepatol (N.Y.). 2011; 7 (5): 337–9.Lin T. Y., Shekar A. O., Li N., Yeh M. W., Saab S., Wilson M. et al. Incidence of abnormal liver biochemical tests in hyperthyroidism. Clin. Endocrinol. (Oxf.). 2017; 86 (5): 755–759. https://doi.org/10.1111/cen.13312Lin T. Y., Shekar A. O., Li N., Yeh M. W., Saab S., Wilson M. et al. Incidence of abnormal liver biochemical tests in hyperthyroidism. Clin. Endocrinol. (Oxf.). 2017; 86 (5): 755–759. https://doi.org/10.1111/cen.13312Sato I., Tsunekawa T., Shinohara Y., Nishio Y., Shimizu Y., Suzuki Y., Yoshioka S. A case of autoimmune hepatitis with Graves' disease treated by propylthiouracil. Nagoya J. Med. Sci. 2011; 73 (3–4): 205–9.Sato I., Tsunekawa T., Shinohara Y., Nishio Y., Shimizu Y., Suzuki Y., Yoshioka S. A case of autoimmune hepatitis with Graves' disease treated by propylthiouracil. Nagoya J. Med. Sci. 2011; 73 (3–4): 205–9.Hsieh A., Adelstein S., McLennan S.V., Williams P. F., Chua E. L., Twigg S. M. Liver enzyme profile and progression in association with thyroid autoimmunity in Graves' disease. Endocrinol. Diabetes. Metab. 2019; 2 (4): e00086. https://doi.org/10.1002/edm2.86Hsieh A., Adelstein S., McLennan S.V., Williams P. F., Chua E. L., Twigg S. M. Liver enzyme profile and progression in association with thyroid autoimmunity in Graves' disease. Endocrinol. Diabetes. Metab. 2019; 2 (4): e00086. https://doi.org/10.1002/edm2.86Malespin M., Nassri A. Endocrine Diseases and the Liver: An Update. Clin. Liver. Dis. 2019; 23 (2): 233–246. https://doi.org/10.1016/j.cld.2018.12.006Malespin M., Nassri A. Endocrine Diseases and the Liver: An Update. Clin. Liver. Dis. 2019; 23 (2): 233–246. https://doi.org/10.1016/j.cld.2018.12.006Vitug A. C., Goldman J. M. Hepatotoxicity from antithyroid drugs. Horm. Res. 1985; 21 (4): 229–34. https://doi.org/10.1159/000180054Vitug A. C., Goldman J. M. Hepatotoxicity from antithyroid drugs. Horm. Res. 1985; 21 (4): 229–34. https://doi.org/10.1159/000180054Liaw Y. F., Huang M. J., Fan K. D., Li K. L., Wu S. S., Chen T. J. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann. Intern. Med. 1993; 118 (6): 424–8. https://doi.org/10.7326/0003–4819–118–6–199303150–00005Liaw Y. F., Huang M. J., Fan K. D., Li K. L., Wu S. S., Chen T. J. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann. Intern. Med. 1993; 118 (6): 424–8. https://doi.org/10.7326/0003–4819–118–6–199303150–00005Niculescu D. A., Dusceac R., Galoiu S. A., Capatina C. A., Poiana C. Serial changes of liver function tests before and during methimazole treatment in thyrotoxic patients. Endocr. Pract. 2016; 22 (8): 974–9. https://doi.org/10.4158/EP161222.ORNiculescu D. A., Dusceac R., Galoiu S. A., Capatina C. A., Poiana C. Serial changes of liver function tests before and during methimazole treatment in thyrotoxic patients. Endocr. Pract. 2016; 22 (8): 974–9. https://doi.org/10.4158/EP161222.ORBurch H. B., Cooper D. S., Management of Graves Disease: A Review. JAMA. 2015; 314 (23): 2544–54. https://doi.org/10.1001/jama.2015.16535Burch H. B., Cooper D. S., Management of Graves Disease: A Review. JAMA. 2015; 314 (23): 2544–54. https://doi.org/10.1001/jama.2015.16535Nakamura H., Noh J. Y., Itoh K., Fukata S., Miyauchi A., Hamada N. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J. Clin. Endocrinol. Metab. 2007; 92 (6): 2157–62. https://doi.org/10.1210/jc.2006–2135Nakamura H., Noh J. Y., Itoh K., Fukata S., Miyauchi A., Hamada N. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J. Clin. Endocrinol. Metab. 2007; 92 (6): 2157–62. https://doi.org/10.1210/jc.2006–2135Ruiz J. K., Rossi G. V., Vallejos H. A., Brenet R. W., Lopez I. B., Escribano A. A. Ful-minant hepatic failure associated with propylthiouracil. Ann. Pharmacother. 2003; 37 (2): 224–8. https://doi.org/10.1177/106002800303700213Ruiz J. K., Rossi G. V., Vallejos H. A., Brenet R. W., Lopez I. B., Escribano A. A. Ful-minant hepatic failure associated with propylthiouracil. Ann. Pharmacother. 2003; 37 (2): 224–8. https://doi.org/10.1177/106002800303700213Ross D. S., Burch H. B., Cooper D. S., Greenlee M. C., Laurberg P., Maia A. L. et al. 2016 American Thyroid Association Guidelines for Diagnosis and Manage-ment of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016; 26 (10): 1343–1421. https://doi.org/10.1089/thy.2016.0229Ross D. S., Burch H. B., Cooper D. S., Greenlee M. C., Laurberg P., Maia A. L. et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016; 26 (10): 1343–1421. https://doi.org/10.1089/thy.2016.0229

The authors declare that there are no conflicts of interest present.